NexGel Inc (NXGL)
2.23
+0.03
(+1.36%)
USD |
NASDAQ |
May 02, 16:00
2.25
+0.02
(+0.90%)
After-Hours: 20:00
NexGel Enterprise Value: 12.49M for May 2, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 12.49M |
| May 01, 2024 | 12.31M |
| April 30, 2024 | 11.81M |
| April 29, 2024 | 11.68M |
| April 26, 2024 | 12.37M |
| April 25, 2024 | 12.84M |
| April 24, 2024 | 12.37M |
| April 23, 2024 | 12.31M |
| April 22, 2024 | 12.18M |
| April 19, 2024 | 12.12M |
| April 18, 2024 | 12.37M |
| April 17, 2024 | 12.65M |
| April 16, 2024 | 12.06M |
| April 15, 2024 | 12.18M |
| April 12, 2024 | 12.18M |
| April 11, 2024 | 12.37M |
| April 10, 2024 | 11.93M |
| April 09, 2024 | 11.24M |
| April 08, 2024 | 11.32M |
| April 05, 2024 | 10.95M |
| April 04, 2024 | 11.70M |
| April 03, 2024 | 11.93M |
| April 02, 2024 | 12.27M |
| April 01, 2024 | 11.47M |
| March 28, 2024 | 14.28M |
| Date | Value |
|---|---|
| March 27, 2024 | 13.94M |
| March 26, 2024 | 14.29M |
| March 25, 2024 | 14.28M |
| March 22, 2024 | 13.82M |
| March 21, 2024 | 13.82M |
| March 20, 2024 | 13.94M |
| March 19, 2024 | 13.59M |
| March 18, 2024 | 14.57M |
| March 15, 2024 | 13.48M |
| March 14, 2024 | 13.48M |
| March 13, 2024 | 14.80M |
| March 12, 2024 | 15.03M |
| March 11, 2024 | 14.40M |
| March 08, 2024 | 14.71M |
| March 07, 2024 | 15.63M |
| March 06, 2024 | 15.60M |
| March 05, 2024 | 14.74M |
| March 04, 2024 | 14.62M |
| March 01, 2024 | 12.47M |
| February 29, 2024 | 12.50M |
| February 28, 2024 | 12.33M |
| February 27, 2024 | 11.87M |
| February 26, 2024 | 11.75M |
| February 23, 2024 | 12.10M |
| February 22, 2024 | 11.96M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-1.564M
Minimum
Mar 08 2022
19.90M
Maximum
Dec 22 2021
5.014M
Average
2.971M
Median
Enterprise Value Benchmarks
| Anika Therapeutics Inc | 336.25M |
| The Cooper Companies Inc | 20.48B |
| Staar Surgical Co | 2.003B |
| OrthoPediatrics Corp | 689.01M |
| Innovative Eyewear Inc | -1.426M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.098M |
| Revenue (Quarterly) | 1.082M |
| Total Expenses (Quarterly) | 2.301M |
| EPS Diluted (Quarterly) | -0.20 |
| Gross Profit Margin (Quarterly) | 14.60% |
| Profit Margin (Quarterly) | -101.5% |
| Earnings Yield | -25.56% |
| Normalized Earnings Yield | -27.82 |